Drug studies sponsored by drug manufacturers tend to report higher drug efficacy than studies not sponsored by drug companies, a report published in the Journal of Political Economy on Oct. 7 found.
The report found a “sponsorship effect” that tends to bias sponsored studies toward reporting higher drug efficacies. The author could not find differences in study design between those funded by drug companies and those not.
